MONTVALE, N.J., Feb. 7 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Jim Sulat, President and Chief Executive Officer, will provide a Company update at the Bio CEO & Investor Conference 2007 on Wednesday, February 14, 2007 at 12:45 p.m. ET, at the Waldorf=Astoria, New York City.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals' website at http://www.memorypharma.com/. An archived version of the webcast will be available at the same location through Wednesday, February 21, 2007.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com/.
